Strata Critical Medical (SRTA) Shares Outstanding (Diluted Average) (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $90.2 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 12.86% year-over-year to $90.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90.2 million (up 12.86% YoY) and the FY2025 annual result came in at $82.1 million, up 5.93% from the prior year.
• Shares Outstanding (Diluted Average) improved to $90.2 million in Q1 2026 per SRTA's latest filing, from $82.1 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $90.2 million in Q1 2026 and bottomed at $70.8 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $77.2 million (2024), against an average of $76.9 million.
• Peak annual rise in Shares Outstanding (Diluted Average) reached 171.17% in 2022, while the deepest fall reached 8.3% in 2022.
• Tracing SRTA's Shares Outstanding (Diluted Average) over 5 years: stood at $71.2 million in 2022, then advanced by 3.21% to $73.5 million in 2023, then rose by 5.41% to $77.5 million in 2024, then climbed by 5.93% to $82.1 million in 2025, then climbed by 9.84% to $90.2 million in 2026.
• Per Business Quant, the three latest SRTA Shares Outstanding (Diluted Average) figures stand at $90.2 million (Q1 2026), $82.1 million (Q4 2025), and $81.2 million (Q3 2025).

Peer Comparison